News

Outbrain's 2024 Year-End Results: Growth and Insights

Outbrain's 2024 Year-End Results: Growth and Insights

Outbrain's 2024 Year-End Financial Overview

Outbrain Inc. (NASDAQ: OB), now branded as Teads, has released its financial results for the year ending December 31, 2024. The company showcased impressive growth and established new benchmarks in profitability after completing its key merger earlier this year.

Key Financial Metrics for 2024

In the fourth quarter, Outbrain reported revenue of $234.6 million, reflecting a 5% decrease from the previous year’s $248.2 million, primarily attributed to unfavorable foreign currency effects. However, the gross profit for the quarter reached $56.1 million, marking a 5% increase compared to $53.2 million last year.

Growth in Gross Profit

Despite the revenue dip, Outbrain experienced a commendable increase in its gross margin, which rose to 23.9% from 21.4% year-over-year. The significant improvement in gross profit can be correlated with strategic operational efficiencies post-merger with Teads.

Adjusted EBITDA and Net Income Highlights

Outbrain's Adjusted EBITDA for the fourth quarter stood at $17 million, a rise from $14 million the prior year. This marks a clear trend of enhancing operational efficiency. The company’s net loss for Q4 was minimal at $0.2 million, a turnaround from a net income of $4.1 million in the same period the previous year.

Strategic Advances Through the Teads Merger

The merger completed in early February holds considerable promise. David Kostman, CEO of Outbrain, expressed excitement in merging Outbrain's and Teads' capabilities to become a leader in the Open Internet advertising sector. This merger is perceived as a unique opportunity to efficiently connect brands with target audiences across diverse platforms.

Acquisition Insights and Future Expectations

The acquisition valued at approximately $900 million included both cash and Outbrain shares, and is expected to yield substantial synergies of $65 million to $75 million annually by 2026. The company plans to focus on significant cost synergies while further evolving its media strategy.

Fourth Quarter Positive Trends

Outbrain reported continuous year-over-year growth in Ex-TAC gross profit, showcasing achievements in both revenue generation and operational optimization. This positive performance trend is a testament to the solid reception of its new product offerings such as the Moments feature and the support from premium supply partners.

Conclusion on 2024 Trends and 2025 Guidance

Looking ahead, Outbrain anticipates adjusted EBITDA to exceed $180 million for the full year 2025. Their commitment to harnessing the strengths of the Teads acquisition reflects a strong foundation for growth in the coming year.

Frequently Asked Questions

What were Outbrain’s revenue figures for 2024?

Outbrain reported revenues of $889.9 million for the full year 2024.

How did the merger with Teads impact Outbrain's performance?

The merger enhanced Outbrain's capabilities, allowing for greater operational efficiencies and solid revenue generation strategies.

What is Adjusted EBITDA, and what was it for Q4 2024?

Adjusted EBITDA is a measure of a company’s operational profitability, and Outbrain reported $17 million for Q4 2024.

What challenges impacted Outbrain’s revenue in 2024?

Unfavorable foreign currency effects were a partial contributor to the revenue decline compared to the previous year.

What is expected for Outbrain’s guidance in 2025?

Outbrain expects Adjusted EBITDA of at least $180 million in 2025, continuing its growth momentum.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles